Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-06-25

FDA Approved: ACITRETIN — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for ACITRETIN from Mylan Pharmaceuticals Inc., resulting in updated labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acitretin (Acitretin)

Snippet

SUPPL AP for ACITRETIN (ACITRETIN)